Literature DB >> 23775679

Sixth hour transcutaneous bilirubin predicting significant hyperbilirubinemia in ABO incompatible neonates.

Ramesh Y Bhat1, Pavan C G Kumar.   

Abstract

BACKGROUND: Neonates with ABO hemolytic disease are at greater risk for developing significant hyperbilirubinemia. We aimed to determine whether sixth hour transcutaneous bilirubin (TcB) could predict such a risk.
METHODS: TcB measurements were obtained at the 6th hour of life in blood group A or B neonates born to blood group O, rhesus factor compatible mothers. Subsequent hyperbilirubinemia was monitored and considered significant if a neonate required phototherapy/exchange transfusion. The predictive role of sixth hour TcB was estimated.
RESULTS: Of 144 ABO incompatible neonates, 41(OA, 24; O-B, 17) had significant hyperbilirubinemia. Mean sixth hour TcB was significantly higher among neonates who developed significant hyperbilirubinemia than those who did not (5.83±1.35 mg/dL vs. 3.65±0.96 mg/dL, P<0.001). Sixth hour TcB value >4 mg/dL had the highest sensitivity of 93.5% and >6 mg/dL had the highest specificity of 99%. Area under receiver operating characteristic curve was 0.898.
CONCLUSION: Sixth hour TcB predicts subsequent significant hyperbilirubinemia in ABO incompatible neonates.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23775679     DOI: 10.1007/s12519-013-0421-5

Source DB:  PubMed          Journal:  World J Pediatr            Impact factor:   2.764


  26 in total

1.  Neonatal jaundice due to ABO incompatibility in Sri Lankan.

Authors:  G N Lucas
Journal:  Indian J Pediatr       Date:  1996 May-Jun       Impact factor: 1.967

2.  The value of first-day bilirubin measurement in predicting the development of significant hyperbilirubinemia in healthy term newborns.

Authors:  F Alpay; S U Sarici; H D Tosuncuk; M A Serdar; N Inanç; E Gökçay
Journal:  Pediatrics       Date:  2000-08       Impact factor: 7.124

Review 3.  Diagnosis and management of hyperbilirubinemia in the term neonate: for a safer first week.

Authors:  Vinod K Bhutani; Lois H Johnson; Ron Keren
Journal:  Pediatr Clin North Am       Date:  2004-08       Impact factor: 3.278

Review 4.  Assessing jaundice in infants of 35-week gestation and greater.

Authors:  Meredith Lease; Bonny Whalen
Journal:  Curr Opin Pediatr       Date:  2010-06       Impact factor: 2.856

5.  Transcutaneous bilirubin in predicting hyperbilirubinemia in term neonates.

Authors:  Y Ramesh Bhat; Amitha Rao
Journal:  Indian J Pediatr       Date:  2008-02       Impact factor: 1.967

6.  What is the best predictor of the severity of ABO-haemolytic disease of the newborn?

Authors:  H A Brouwers; M A Overbeeke; I van Ertbruggen; W Schaasberg; G P Alsbach; C van der Heiden; E F van Leeuwen; J W Stoop; C P Engelfriet
Journal:  Lancet       Date:  1988-09-17       Impact factor: 79.321

7.  Length of stay, jaundice, and hospital readmission.

Authors:  M J Maisels; E Kring
Journal:  Pediatrics       Date:  1998-06       Impact factor: 7.124

8.  A guide to the use of phototherapy in the management of neonatal hyperbilirubinemia. Commentary.

Authors:  W T Speck
Journal:  J Pediatr       Date:  1979-08       Impact factor: 4.406

9.  The value of transcutaneous method of bilirubin measurement in newborn population with the risk of ABO hemolytic disease.

Authors:  Dalia Stoniene; Jūrate Buinauskiene; Egle Markūniene
Journal:  Medicina (Kaunas)       Date:  2009       Impact factor: 2.430

10.  Predictive ability of a predischarge hour-specific serum bilirubin for subsequent significant hyperbilirubinemia in healthy term and near-term newborns.

Authors:  V K Bhutani; L Johnson; E M Sivieri
Journal:  Pediatrics       Date:  1999-01       Impact factor: 7.124

View more
  2 in total

1.  Quantitative and multiplexed detection for blood typing based on quantum dot-magnetic bead assay.

Authors:  Ting Xu; Qiang Zhang; Ya-Han Fan; Ru-Qing Li; Hua Lu; Shu-Ming Zhao; Tian-Lun Jiang
Journal:  Int J Nanomedicine       Date:  2017-04-26

2.  Transcutaneous bilirubin level to predict hyperbilirubinemia in preterm neonates.

Authors:  Dewi Rahmawati; Mahendra Tri Arif Sampurna; Risa Etika; Martono Tri Utomo; Arend F Bos
Journal:  F1000Res       Date:  2020-04-28
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.